Jane C. Davies

Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.

Xiaohong Huang, Michael P Boyle, Carla Colombo, 2015, The New England journal of medicine.

CFTR biomarkers: time for promotion to surrogate end-point

M. Amaral, N. Derichs, M. Proesmans, 2012, European Respiratory Journal.

Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective.

J. Pilewski, S. Donaldson, M. Konstan, 2023, The Lancet Respiratory Medicine.

Potentiators and Correctors in Paediatric Cystic Fibrosis Patients: A Narrative Review

J. Davies, C. Edmondson, R. Dobra, 2018, Pediatric Drugs.

Cystic fibrosis drug trial design in the era of CFTR modulators associated with substantial clinical benefit: stakeholders' consensus view.

M. Amaral, E. Kerem, P. Dřevínek, 2020, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.